To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene C11orf68TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
231 supporting clones for gene C11orf68 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ083428 stomach .a 1 to 225 225 to 1   tiling clone, Submitted on the opposite strand 225/225
(100 %)
0 diff
(100 %id)
BQ674684 epidermoid carcinoma, cell line, salivary gland .a 20 to 495 1 to 483       483/1236
(39 %)
27 diff
(97.9 %id)
BQ072527 pooled lung and spleen .a 29 to 804 1 to 776       776/1035
(74 %)
9 diff
(99.2 %id)
BX354992 Neuroblastoma Cot 25-normalized .a 64 to 1034 1 to 963       963/963
(100 %)
16 diff
(98.4 %id)
NM_001135635.1   .a 77 to 1632 1 to 1556   RefSeq, AAA   1556/1556
(100 %)
2 diff
(99.9 %id)
CR607649 Neuroblastoma Cot 25-normalized .a 94 to 1577 1 to 1484   tiling clone,   1484/1484
(100 %)
0 diff
(100 %id)
BX438438 neuroblastoma .a 94 to 1140 1 to 1033       1033/1094
(94 %)
50 diff
(95.5 %id)
BX345572 Neuroblastoma Cot 25-normalized .a 94 to 732 1 to 635   fully sequenced,   635/635
(100 %)
12 diff
(98.2 %id)
BU180543 epidermoid carcinoma, cell line, salivary gland .a 96 to 386 1 to 292       292/525
(55 %)
8 diff
(98.5 %id)
BQ879424 epidermoid carcinoma, cell line, salivary gland .a 96 to 716 1 to 632       632/1016
(62 %)
16 diff
(98.5 %id)
BQ675036 epidermoid carcinoma, cell line, salivary gland .a 96 to 635 1 to 549       549/1411
(38 %)
16 diff
(98.9 %id)
CX866110 embryonic stem .a 101 to 768 1 to 668       668/668
(100 %)
1 diff
(99.9 %id)
BQ067020 brain .a 110 to 782 9 to 681       673/1062
(63 %)
36 diff
(96.7 %id)
BX458972 placenta .a 115 to 1020 1 to 898       898/909
(98 %)
29 diff
(96.9 %id)
CX870652 embryonic stem .a 117 to 759 1 to 643       643/643
(100 %)
2 diff
(99.7 %id)
TI_57146900   .a 119 to 899 26 to 806       781/807
(96 %)
8 diff
(99.1 %id)
BQ919450 large cell carcinoma, lung .a 124 to 579 1 to 457       457/1156
(39 %)
10 diff
(99.2 %id)
BI760854 pooled colon, kidney, stomach .a 125 to 899 1 to 775       775/776
(99 %)
2 diff
(99.8 %id)
BG911599.
matches multiple genes
anaplastic oligodendroglioma with 1p/19qloss, brain, Brain, anaplastic oligodendroglioma with1p/19q loss .a 128 to 661 1 to 563   available from MGC, also hits gene zuleeby 563/697
(80 %)
25 diff
(96.5 %id)
CX787057 human embryonic stem cells .a 134 to 843 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
BG116724 duodenal adenocarcinoma, cell line, small intestine .a 143 to 549 1 to 409       409/409
(100 %)
2 diff
(99.6 %id)
BQ441792 epithelioid carcinoma, Pancreas .a 145 to 485 1 to 345       345/932
(37 %)
10 diff
(99.0 %id)
BQ217561 melanotic melanoma, skin .a 185 to 705 1 to 528       528/944
(55 %)
9 diff
(99.1 %id)
TI_57216710   .a 201 to 1132 29 to 952       924/952
(97 %)
26 diff
(97.3 %id)
BI756759 brain .a 207 to 1132 1 to 918       918/918
(100 %)
20 diff
(97.9 %id)
BM558562 duodenal adenocarcinoma, cell line, small intestine .a 222 to 1033 1 to 815       815/1038
(78 %)
14 diff
(98.7 %id)
BF688486 eye, normal pigmented retinal epithelium .a 225 to 844 120 to 754   fully sequenced,   635/754
(84 %)
63 diff
(91.7 %id)
TI_1948073650   .a 232 to 990 139 to 897   fully sequenced,   759/897
(84 %)
6 diff
(99.4 %id)
TI_1948073997   .a 232 to 984 134 to 888       755/1130
(66 %)
5 diff
(99.6 %id)
TI_1948074174   .a 232 to 986 132 to 888   fully sequenced, AAA   757/888
(85 %)
9 diff
(99.0 %id)
TI_1948073651   .a 440 to 991 680 to 126   fully sequenced,   555/680
(81 %)
11 diff
(98.4 %id)
TI_1948074175   .a 678 to 991 440 to 125   fully sequenced,   316/440
(71 %)
6 diff
(98.7 %id)
BX345571 Neuroblastoma Cot 25-normalized .a 702 to 1577 888 to 1   fully sequenced,   888/888
(100 %)
26 diff
(97.1 %id)
BF689295 eye, normal pigmented retinal epithelium .a 814 to 1577 786 to 18   fully sequenced,   769/786
(97 %)
21 diff
(97.4 %id)
CX866030 embryonic stem .a 1149 to 1617 495 to 26   tiling clone, AAA   470/470
(100 %)
1 diff
(99.8 %id)
DB490861 hypothalamus .b 1 to 288 1 to 289   tiling clone,   289/299
(96 %)
16 diff
(94.7 %id)
BC013185 Adrenal cortex, carcinoma .b 3 to 1555 1 to 1553 Q195R tiling clone, available from MGC, AAA   1553/1553
(100 %)
3 diff
(99.9 %id)
NM_031450.3   .b 3 to 1555 1 to 1553 exact RefSeq, AAA   1553/1553
(100 %)
2 diff
(99.9 %id)
BX425244 neuroblastoma .b 4 to 880 1 to 886       886/1006
(88 %)
30 diff
(97.1 %id)
CR609409 Placenta Cot 25-normalized .b 4 to 1475 1 to 1472 exact     1472/1472
(100 %)
0 diff
(100 %id)
BX335758 Placenta Cot 25-normalized .b 4 to 659 1 to 653   fully sequenced,   653/653
(100 %)
3 diff
(99.6 %id)
CA388944 eye, RPE/choroid .b 4 to 389 1 to 386       386/386
(100 %)
0 diff
(100 %id)
BF793590 adrenal cortex carcinoma, cell line, adrenal gland .b 4 to 472 1 to 470       470/470
(100 %)
1 diff
(99.8 %id)
AI351004   .b 11 to 199 1 to 189     Submitted on the opposite strand 189/189
(100 %)
0 diff
(100 %id)
TI_57171467   .b 11 to 828 53 to 881       829/887
(93 %)
29 diff
(96.8 %id)
DN997326 breast cancer, Mammary gland (cancer tissue) .b 12 to 815 1 to 803       803/803
(100 %)
9 diff
(98.9 %id)
DR157006 human embryonic stem cells differentiated toan early endodermal cell type .b 14 to 831 1 to 818       818/818
(100 %)
2 diff
(99.8 %id)
BM560330 astrocytoma grade IV, cell line, brain .b 16 to 475 1 to 462       462/1117
(41 %)
6 diff
(99.5 %id)
BQ277718 ovary, teratocarcinoma, cell line .b 17 to 659 1 to 646       646/1034
(62 %)
10 diff
(99.1 %id)
CR594297 Placenta Cot 25-normalized .b 20 to 1497 1 to 1478 exact     1478/1478
(100 %)
0 diff
(100 %id)
CR595046 fetal brain .b 20 to 1530 1 to 1511 exact tiling clone,   1511/1511
(100 %)
0 diff
(100 %id)
CR604272 neuroblastoma .b 20 to 1501 1 to 1482 exact     1482/1482
(100 %)
0 diff
(100 %id)
AL518693 brain, neuroblastoma, neuroblastoma cells .b 20 to 720 1 to 687   fully sequenced,   687/687
(100 %)
7 diff
(99.0 %id)
BX460444 brain, fetal brain .b 20 to 968 1 to 950 E20D P21A S26X R27G A28P ...     950/950
(100 %)
9 diff
(99.1 %id)
BX463895 brain, fetal brain .b 20 to 965 1 to 934 E20X P21H R22G Q23R E24S ...     934/1049
(89 %)
18 diff
(98.3 %id)
AL544687 placenta, Placenta Cot 25-normalized .b 20 to 913 1 to 890 E20X P21H R22G Q23R E24S ...     890/890
(100 %)
8 diff
(99.2 %id)
BX343785 Placenta Cot 25-normalized .b 20 to 1039 1 to 1005 A2X E20D P21H R22G Q23R ...     1005/1016
(98 %)
31 diff
(97.0 %id)
AL557963 T cells from T cell leukemia .b 20 to 780 1 to 746   fully sequenced,   746/746
(100 %)
3 diff
(99.6 %id)
BX383294.
matches multiple genes
  .b 20 to 1024 1 to 990 P21H R22G Q23R E24S R25G ...   also hits gene PDCL 990/1012
(97 %)
33 diff
(96.8 %id)
CD671074 eye, Iris .b 20 to 444 1 to 425       425/425
(100 %)
3 diff
(99.3 %id)
BI827572 brain, medulla .b 20 to 828 1 to 820       820/826
(99 %)
24 diff
(97.1 %id)
BM906742 ovary (pool of 3) .b 20 to 1046 9 to 1054 A3V Q195R R204P K206Q I233L ...     1046/1086
(96 %)
73 diff
(93.3 %id)
BX375514 Neuroblastoma Cot 25-normalized .b 21 to 1014 1 to 983 E20X P21H R22G Q23R E24S ...     983/990
(99 %)
21 diff
(97.9 %id)
CD579701 brain .b 33 to 671 1 to 639       639/643
(99 %)
17 diff
(97.4 %id)
CN366127 embryonic stem cells, cell lines H1, H7, andH9 .b 35 to 662 5 to 632       628/632
(99 %)
7 diff
(98.9 %id)
CN366129 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 37 to 642 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
BQ650992 hepatocellular carcinoma, cell line, Liver .b 37 to 770 26 to 765       740/983
(75 %)
22 diff
(97.8 %id)
BQ653689 hepatocellular carcinoma, cell line, Liver .b 38 to 705 1 to 677       677/878
(77 %)
17 diff
(98.1 %id)
CR979626 T-Lymphocytes .b 38 to 717 1 to 680       680/680
(100 %)
2 diff
(99.8 %id)
BX353474 Neuroblastoma Cot 25-normalized .b 40 to 921 1 to 882       882/882
(100 %)
6 diff
(99.4 %id)
CR747794 pooled pancreas and spleen .b 48 to 573 1 to 526       526/526
(100 %)
0 diff
(100 %id)
CR749108 pooled lung and spleen .b 48 to 568 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BG751006 eye, normal pigmented retinal epithelium .b 49 to 802 1 to 771       771/887
(86 %)
27 diff
(97.0 %id)
BM923634 pooled colon, kidney, stomach .b 58 to 929 7 to 882       876/1088
(80 %)
26 diff
(97.7 %id)
BU163646 melanotic melanoma, cell line, skin .b 59 to 605 1 to 562       562/1103
(50 %)
32 diff
(97.1 %id)
BI819255 pooled brain, lung, testis .b 61 to 892 48 to 887       840/887
(94 %)
33 diff
(96.3 %id)
TI_57197701   .b 61 to 892 85 to 924       840/924
(90 %)
33 diff
(96.5 %id)
TI_57183454   .b 64 to 940 70 to 959       890/959
(92 %)
29 diff
(97.0 %id)
BE886337 leiomyosarcoma, uterus .b 66 to 452 1 to 387       387/387
(100 %)
0 diff
(100 %id)
BG024832 lymph, lymphoma, cell line .b 67 to 472 1 to 406       406/406
(100 %)
0 diff
(100 %id)
CD514535 White Matter .b 67 to 824 25 to 791       767/917
(83 %)
22 diff
(97.7 %id)
BI770547 pooled lung and spleen .b 69 to 940 1 to 885       885/885
(100 %)
23 diff
(97.5 %id)
BE887821 leiomyosarcoma, uterus .b 76 to 452 1 to 378       378/378
(100 %)
4 diff
(99.0 %id)
BM804992 ovary (pool of 3) .b 90 to 671 40 to 624       585/1476
(39 %)
37 diff
(97.5 %id)
BG751367 eye, normal pigmented retinal epithelium .b 91 to 1058 1 to 969       969/1036
(93 %)
40 diff
(96.2 %id)
AF073483 mesothelium .b 94 to 1538 1 to 1445   AAA   1445/1445
(100 %)
3 diff
(99.8 %id)
BM705907 eye, lens .b 140 to 714 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BX396585 Placenta Cot 25-normalized .b 629 to 1475 840 to 1   fully sequenced,   840/840
(100 %)
5 diff
(99.5 %id)
AL561744 brain, neuroblastoma, neuroblastoma cells .b 690 to 1500 804 to 1   fully sequenced,   804/804
(100 %)
16 diff
(98.1 %id)
BM664311 eye, lens .b 1218 to 1538 331 to 11   AAA   321/321
(100 %)
1 diff
(99.7 %id)
BX351047 Neuroblastoma Cot 25-normalized .b 1230 to 1535 306 to 1       306/346
(88 %)
6 diff
(98.3 %id)
AL579892 T cells from T cell leukemia .b 1276 to 1466 199 to 8   fully sequenced,   682/689
(98 %)
30 diff
(95.7 %id)
TI_154104276   .c-u 1 to 864 41 to 894   tiling clone, Submitted on the opposite strand 854/1065
(80 %)
6 diff
(99.5 %id)
BM721109 eye, fetal eye .c-u 15 to 721 1 to 706   tiling clone,   706/709
(99 %)
4 diff
(99.5 %id)
BC010512 Brain, glioblastoma with EGFR amplification .c-u 130 to 1657 1 to 1528 Q154R available from MGC, AAA   1528/1528
(100 %)
3 diff
(99.9 %id)
BG394174 eye, retinoblastoma .c-u 275 to 1047 1 to 774 Y210L L211P G212W I213A Y214S ...     774/963
(80 %)
25 diff
(97.5 %id)
CV023405 mixed .c-u 276 to 905 1 to 630       630/630
(100 %)
2 diff
(99.7 %id)
BQ938474 epidermoid carcinoma, cell line, lung .c-u 287 to 1105 1 to 826       826/843
(97 %)
15 diff
(98.3 %id)
BC004414 Pancreas, adenocarcinoma .c-u 297 to 1676 1 to 1380   available from MGC, AAA   1380/1380
(100 %)
3 diff
(99.8 %id)
BE736533 adenocarcinoma, Pancreas .c-u 319 to 859 1 to 549   available from MGC,   549/549
(100 %)
14 diff
(97.5 %id)
BQ428176 leiomyosarcoma, uterus .c-u 324 to 1089 12 to 779       768/865
(88 %)
16 diff
(98.2 %id)
CN366128 embryonic stem cells, cell lines H1, H7, andH9 .c-u 336 to 904 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BM721347 eye, fetal eye .c-u 337 to 1020 1 to 684       684/684
(100 %)
1 diff
(99.9 %id)
BQ653898 hepatocellular carcinoma, cell line, Liver .c-u 365 to 1189 18 to 859       842/893
(94 %)
30 diff
(96.7 %id)
R85159 brain .c-u 414 to 592 1 to 177       177/177
(100 %)
2 diff
(98.9 %id)
BF975741 B-cells, primary B-cells from tonsils (cell line) .c-u 417 to 1158 1 to 736       736/737
(99 %)
10 diff
(98.7 %id)
BG029209 Bone, osteosarcoma, cell line .c-u 450 to 593 1 to 144       144/144
(100 %)
0 diff
(100 %id)
TI_1948073821   .c-u 456 to 1030 710 to 128       583/1446
(40 %)
0 diff
(100 %id)
TI_1948074194   .c-u 494 to 1030 668 to 128       541/1283
(42 %)
0 diff
(100 %id)
CR620048 T cells (Jurkat cell line) Cot10-normalized .c-u 506 to 1642 1 to 1137   tiling clone,   1137/1137
(100 %)
0 diff
(100 %id)
AL559610 T cells from T cell leukemia .c-u 506 to 1503 1 to 978       978/1009
(96 %)
21 diff
(98.0 %id)
BG823606 adenocarcinoma cell line, colon .c-u 507 to 1222 1 to 714       714/714
(100 %)
7 diff
(99.1 %id)
BG112385 Bone, osteosarcoma, cell line .c-u 522 to 593 1 to 72       72/72
(100 %)
2 diff
(97.3 %id)
BE512836 adenocarcinoma cell line, colon .c-u 528 to 1279 1 to 772       772/1059
(72 %)
46 diff
(95.7 %id)
BX355447 Neuroblastoma Cot 50-normalized .c-u 536 to 1638 1101 to 1       1101/1101
(100 %)
62 diff
(94.4 %id)
BM129709 Islets of Langerhans, Pancreas .c-u 541 to 1037 1 to 497       497/497
(100 %)
2 diff
(99.6 %id)
CB051696 leiomyosarcoma, soft tissue .c-u 604 to 1108 4 to 508   fully sequenced,   505/508
(99 %)
20 diff
(96.1 %id)
BE382476 brain, neuroblastoma .c-u 622 to 1264 1 to 639       639/639
(100 %)
13 diff
(98.0 %id)
BX343784 Placenta Cot 25-normalized .c-u 625 to 1603 999 to 22       978/1039
(94 %)
0 diff
(100 %id)
BX463894 brain, fetal brain .c-u 678 to 1624 938 to 1       938/943
(99 %)
19 diff
(98.0 %id)
CD672783 eye, Iris .c-u 698 to 1318 1 to 621       621/621
(100 %)
4 diff
(99.4 %id)
AL570728 placenta, Placenta Cot 25-normalized .c-u 716 to 1618 902 to 1       902/902
(100 %)
13 diff
(98.6 %id)
N53886 multiple sclerosis lesions .c-u 767 to 1133 1 to 366       366/366
(100 %)
6 diff
(98.4 %id)
AA375643 lung .c-u 771 to 1020 1 to 250       250/250
(100 %)
0 diff
(100 %id)
BE158217 head_neck .c-u 788 to 1015 229 to 1     Submitted on the opposite strand 229/229
(100 %)
2 diff
(99.2 %id)
BG821005 anaplastic oligodendroglioma with 1p/19qloss, brain .c-u 789 to 1627 12 to 856       845/857
(98 %)
41 diff
(95.3 %id)
CR743441 anaplastic oligodendroglioma, brain .c-u 794 to 1256 1 to 463       463/463
(100 %)
2 diff
(99.6 %id)
TI_154055837   .c-u 828 to 1659 934 to 108   AAA   827/918
(90 %)
31 diff
(96.7 %id)
BM692385 eye, human retina .c-u 845 to 1250 2 to 407   fully sequenced,   406/407
(99 %)
7 diff
(98.3 %id)
AW751057 colon .c-u 849 to 1274 6 to 431       426/439
(97 %)
6 diff
(98.7 %id)
TI_151723785   .c-u 858 to 1676 890 to 82   AAA   809/892
(90 %)
26 diff
(97.1 %id)
BF340767 brain, glioblastoma with EGFR amplification .c-u 863 to 1411 83 to 665       583/892
(65 %)
33 diff
(96.4 %id)
BM716631 eye, fetal eyes .c-u 901 to 1674 1 to 774   fully sequenced,   774/774
(100 %)
4 diff
(99.5 %id)
TI_151798565   .c-u 901 to 1409 118 to 633       516/833
(61 %)
18 diff
(97.9 %id)
BX413046 brain, fetal brain .c-u 902 to 1651 752 to 1       752/873
(86 %)
27 diff
(97.0 %id)
BU844518 ovary, teratocarcinoma, cell line .c-u 908 to 1667 790 to 28     Submitted on the opposite strand 763/914
(83 %)
0 diff
(100 %id)
BG741492 skin .c-u 925 to 1661 1 to 739       739/749
(98 %)
7 diff
(99.1 %id)
N24225 melanocyte .c-u 931 to 1391 1 to 460       460/461
(99 %)
7 diff
(98.5 %id)
BQ446694 Knee, Osteoarthritic Cartilage .c-u 952 to 1659 726 to 19   AAA   708/708
(100 %)
4 diff
(99.5 %id)
TI_154123474   .c-u 955 to 1676 807 to 95   AAA   713/905
(78 %)
13 diff
(98.6 %id)
TI_154126383   .c-u 955 to 1676 776 to 65   AAA   712/963
(73 %)
18 diff
(98.2 %id)
CA413297 Chondrosarcoma Grade II, Left Pelvis .c-u 959 to 1676 736 to 19   AAA   718/718
(100 %)
4 diff
(99.5 %id)
TI_149309136   .c-u 960 to 1676 811 to 95   AAA   717/999
(71 %)
5 diff
(99.5 %id)
AW796190 uterus .c-u 966 to 1564 595 to 4       592/628
(94 %)
0 diff
(100 %id)
U80786   .c-u 996 to 1302 1 to 308       308/308
(100 %)
9 diff
(97.1 %id)
AI350341 carcinoid, lung .c-u 1002 to 1446 1 to 445     Submitted on the opposite strand 445/445
(100 %)
7 diff
(98.5 %id)
BE042950 carcinoid, lung .c-u 1002 to 1513 1 to 512     Submitted on the opposite strand 512/512
(100 %)
7 diff
(98.7 %id)
BQ010474 Chondrosarcoma, Left Pubic Bone .c-u 1002 to 1676 693 to 19   AAA   675/675
(100 %)
4 diff
(99.5 %id)
EC567909 Prostate .c-u 1006 to 1114 1 to 107       107/111
(96 %)
6 diff
(94.6 %id)
CR625973 Placenta Cot 25-normalized .c-u 1014 to 1680 1 to 667       667/667
(100 %)
0 diff
(100 %id)
BG001584 placenta_normal .c-u 1015 to 1155 141 to 2       140/141
(99 %)
0 diff
(100 %id)
BX382520 Placenta Cot 25-normalized .c-u 1017 to 1680 1 to 664       664/664
(100 %)
3 diff
(99.6 %id)
BE063910 breast .c-u 1021 to 1158 24 to 161       138/170
(81 %)
4 diff
(97.7 %id)
BE064020 breast .c-u 1021 to 1152 148 to 16     Submitted on the opposite strand 133/166
(80 %)
0 diff
(100 %id)
CA443832 Fibrosarcoma .c-u 1033 to 1659 645 to 19   AAA   627/628
(99 %)
4 diff
(99.4 %id)
CN366130 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c-u 1042 to 1659 1 to 619   AAA   619/619
(100 %)
2 diff
(99.7 %id)
R77159 placenta .c-u 1044 to 1636 1 to 601       601/603
(99 %)
39 diff
(93.6 %id)
BX100912 placenta .c-u 1045 to 1676 1 to 632   AAA   632/632
(100 %)
1 diff
(99.9 %id)
BF955105 nervous_normal .c-u 1046 to 1370 330 to 7       324/335
(96 %)
0 diff
(100 %id)
BF955110 nervous_normal .c-u 1046 to 1370 330 to 6       325/335
(97 %)
0 diff
(100 %id)
BM700972 eye, human retina .c-u 1046 to 1409 1 to 364   fully sequenced,   364/364
(100 %)
6 diff
(98.4 %id)
BU687558 lung .c-u 1060 to 1676 635 to 19   AAA   617/617
(100 %)
1 diff
(99.9 %id)
AA036981 uterus .c-u 1069 to 1325 1 to 258       258/258
(100 %)
2 diff
(99.3 %id)
BM679535 eye, fetal eye .c-u 1074 to 1676 621 to 19   AAA   603/603
(100 %)
1 diff
(99.9 %id)
BU627144 Bone, Enchondroma cell line .c-u 1074 to 1659 604 to 19   AAA   586/586
(100 %)
1 diff
(99.9 %id)
CB051695 leiomyosarcoma, soft tissue .c-u 1078 to 1655 605 to 28   fully sequenced, AAA   578/578
(100 %)
1 diff
(99.9 %id)
BF740525 bocio_tumor .c-u 1083 to 1597 529 to 18     Submitted on the opposite strand 512/529
(96 %)
0 diff
(100 %id)
CA423823 cell lines, Chondrosarcoma .c-u 1083 to 1676 611 to 19   AAA   593/593
(100 %)
3 diff
(99.5 %id)
AA037266 senescent fibroblast .c-u 1087 to 1657 1 to 567       567/577
(98 %)
14 diff
(97.6 %id)
H41041 brain .c-u 1098 to 1555 1 to 462       462/462
(100 %)
6 diff
(98.8 %id)
DR423637 eye, Pterygium .c-u 1132 to 1676 603 to 59   AAA Submitted on the opposite strand 545/561
(97 %)
0 diff
(100 %id)
AI686645 Prostate .c-u 1134 to 1667 534 to 1       534/534
(100 %)
1 diff
(99.9 %id)
AA928689 adenocarcinoma, colon .c-u 1136 to 1659 523 to 1       523/523
(100 %)
3 diff
(99.5 %id)
BU754260 placenta .c-u 1141 to 1676 553 to 18   AAA   536/536
(100 %)
1 diff
(99.9 %id)
BM129419 Islets of Langerhans, Pancreas .c-u 1142 to 1679 538 to 1       538/538
(100 %)
0 diff
(100 %id)
AI676023 Prostate .c-u 1153 to 1659 517 to 11   AAA   507/507
(100 %)
5 diff
(99.1 %id)
AI830553 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c-u 1161 to 1661 503 to 2       502/503
(99 %)
0 diff
(100 %id)
CA416533 Chondrosarcoma Cell line .c-u 1161 to 1676 533 to 19   AAA   515/515
(100 %)
1 diff
(99.9 %id)
AI937381 anaplastic oligodendroglioma, brain .c-u 1164 to 1676 513 to 1       513/513
(100 %)
0 diff
(100 %id)
AI084647 senescent fibroblast .c-u 1166 to 1659 499 to 6       494/499
(98 %)
0 diff
(100 %id)
AI458953 carcinoid, lung .c-u 1168 to 1659 495 to 4       492/495
(99 %)
0 diff
(100 %id)
AW071852 anaplastic oligodendroglioma, brain .c-u 1175 to 1676 503 to 1       503/503
(100 %)
2 diff
(99.7 %id)
AI655952 pooled germ cell tumors .c-u 1177 to 1676 498 to 1       498/498
(100 %)
2 diff
(99.6 %id)
BE672696 carcinoid, lung .c-u 1192 to 1659 475 to 8       468/475
(98 %)
0 diff
(100 %id)
BQ025400 placenta .c-u 1196 to 1676 499 to 19   AAA   481/490
(98 %)
5 diff
(99.0 %id)
BI860854 breast, mammary adenocarcinoma, cell line .c-u 1198 to 1659 1 to 462       462/526
(87 %)
1 diff
(99.9 %id)
TI_57192343   .c-u 1198 to 1659 57 to 518       462/831
(55 %)
1 diff
(99.9 %id)
BQ025301 placenta .c-u 1202 to 1661 479 to 20   AAA   460/460
(100 %)
11 diff
(97.7 %id)
BU738010 eye, lens .c-u 1203 to 1676 492 to 19   AAA   474/474
(100 %)
3 diff
(99.4 %id)
DB571916 hypothalamus .c-u 1204 to 1666 1 to 463     Submitted on the opposite strand 463/463
(100 %)
5 diff
(99.0 %id)
BF836840 head_neck .c-u 1213 to 1369 6 to 157       152/174
(87 %)
10 diff
(94.3 %id)
BM673631 eye, human retina .c-u 1220 to 1661 460 to 19   fully sequenced, AAA   442/442
(100 %)
6 diff
(98.7 %id)
AA554057 colon .c-u 1231 to 1659 438 to 11   AAA   428/428
(100 %)
4 diff
(99.1 %id)
AW305091 brain, three pooled meningiomas .c-u 1231 to 1660 430 to 1       430/430
(100 %)
1 diff
(99.8 %id)
AA862343 2 pooled tumors (clear cell type), Kidney .c-u 1238 to 1661 430 to 10       421/430
(97 %)
0 diff
(100 %id)
AW134670   .c-u 1239 to 1657 436 to 18   AAA   419/419
(100 %)
0 diff
(100 %id)
AA922848 adenocarcinoma, colon .c-u 1241 to 1659 417 to 1       417/419
(99 %)
21 diff
(95.0 %id)
AW241486 pooled germ cell tumors .c-u 1241 to 1662 446 to 25   AAA   422/422
(100 %)
17 diff
(96.0 %id)
BF588501 colon, colon tumor, RER+ .c-u 1241 to 1655 417 to 3       415/417
(99 %)
0 diff
(100 %id)
AI201902 Prostate .c-u 1242 to 1657 431 to 16   AAA   416/416
(100 %)
0 diff
(100 %id)
BF591008 colon, colon tumor, RER+ .c-u 1243 to 1661 433 to 15   AAA   419/419
(100 %)
0 diff
(100 %id)
BF001731 colon, colon tumor, RER+ .c-u 1245 to 1659 415 to 1       415/415
(100 %)
1 diff
(99.8 %id)
AI161290 brain, glioblastoma (pooled) .c-u 1247 to 1657 414 to 4       411/414
(99 %)
0 diff
(100 %id)
AI655918 pooled germ cell tumors .c-u 1248 to 1662 433 to 21   AAA   413/413
(100 %)
3 diff
(99.3 %id)
AI806814 pooled .c-u 1248 to 1676 440 to 12   AAA   429/429
(100 %)
1 diff
(99.8 %id)
BG026063 Bone, osteosarcoma, cell line .c-u 1249 to 1661 10 to 426       417/921
(45 %)
14 diff
(98.5 %id)
AW512081 lymph node, lymphoma, follicular mixed small and largecell .c-u 1251 to 1660 420 to 11   AAA   410/410
(100 %)
1 diff
(99.8 %id)
AI420187 Prostate .c-u 1253 to 1659 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AW882951 ovary .c-u 1268 to 1614 35 to 382       348/383
(90 %)
12 diff
(96.9 %id)
AW001392 colon, colonic mucosa from 3 patients with Crohn'sdisease .c-u 1276 to 1680 408 to 4       405/408
(99 %)
0 diff
(100 %id)
AI865743 normal prostate, Prostate .c-u 1285 to 1656 375 to 4       372/375
(99 %)
0 diff
(100 %id)
BM730078 insulinoma, Pancreas .c-u 1285 to 1676 8 to 399   AAA   392/399
(98 %)
6 diff
(98.5 %id)
BM512094 insulinoma, Pancreas .c-u 1285 to 1676 8 to 399   fully sequenced, AAA   392/399
(98 %)
6 diff
(98.5 %id)
AW025871 thymus, pooled .c-u 1288 to 1680 397 to 3       395/397
(99 %)
0 diff
(100 %id)
AI042105 senescent fibroblast .c-u 1320 to 1662 370 to 28   AAA   343/359
(95 %)
0 diff
(100 %id)
AI560621 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c-u 1338 to 1680 348 to 6       343/348
(98 %)
0 diff
(100 %id)
AW241430 pooled germ cell tumors .c-u 1344 to 1662 339 to 21   AAA   319/319
(100 %)
11 diff
(96.6 %id)
AW295618   .c-u 1353 to 1661 326 to 18   AAA   309/309
(100 %)
0 diff
(100 %id)
H03478 placenta .c-u 1355 to 1664 323 to 12       312/323
(96 %)
0 diff
(100 %id)
AI828305 adenocarcinoma, Pancreas .c-u 1356 to 1657 317 to 17   AAA   301/301
(100 %)
10 diff
(96.7 %id)
FN075333 breast carcinoma .c-u 1363 to 1452 1 to 89       89/90
(98 %)
2 diff
(97.8 %id)
BG059616 brain, glioblastoma without EGFR amplification .c-u 1364 to 1680 322 to 6       317/322
(98 %)
0 diff
(100 %id)
BI042723 ovary .c-u 1365 to 1656 8 to 298       291/298
(97 %)
6 diff
(98.0 %id)
AI241595 liver and spleen .c-u 1366 to 1680 315 to 1       315/315
(100 %)
0 diff
(100 %id)
AI611287 Prostate .c-u 1369 to 1659 291 to 1       291/291
(100 %)
0 diff
(100 %id)
BX329847 Neuroblastoma Cot 50-normalized .c-u 1370 to 1669 299 to 2       298/299
(99 %)
0 diff
(100 %id)
BM672309 eye, human retina .c-u 1379 to 1659 299 to 19   fully sequenced, AAA   281/281
(100 %)
0 diff
(100 %id)
AW182702 cervix, tumor .c-u 1384 to 1675 292 to 1       292/292
(100 %)
0 diff
(100 %id)
BE328524 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c-u 1385 to 1661 290 to 14   AAA   277/286
(96 %)
2 diff
(99.4 %id)
BX332929 Neuroblastoma Cot 25-normalized .c-u 1394 to 1659 1 to 266       266/266
(100 %)
0 diff
(100 %id)
BG252744 adenocarcinoma, cell line, Liver .c-u 1397 to 1659 1 to 263   AAA   263/263
(100 %)
2 diff
(99.3 %id)
BU738176 eye, fetal eyes .c-u 1399 to 1681 296 to 14   tiling clone, fully sequenced, AAA   283/283
(100 %)
0 diff
(100 %id)
BX331699 Neuroblastoma Cot 25-normalized .c-u 1405 to 1659 1 to 255       255/255
(100 %)
5 diff
(98.1 %id)
AI151121 brain, glioblastoma (pooled) .c-u 1406 to 1676 283 to 13   AAA   271/273
(99 %)
2 diff
(99.3 %id)
AW007302 adenocarcinoma, Pancreas .c-u 1409 to 1676 299 to 31   AAA   269/269
(100 %)
9 diff
(96.7 %id)
BX357767 Placenta Cot 25-normalized .c-u 1439 to 1669 1 to 231       231/242
(95 %)
1 diff
(99.6 %id)
AI696188 pooled germ cell tumors .c-u 1445 to 1662 237 to 21   AAA   217/217
(100 %)
1 diff
(99.6 %id)
BF002314 colon, colon tumor, RER+ .c-u 1450 to 1679 230 to 1       230/230
(100 %)
0 diff
(100 %id)
BM511868 insulinoma, Pancreas .c-u 1463 to 1676 228 to 16   fully sequenced, AAA   213/213
(100 %)
6 diff
(97.2 %id)
BF476322 Prostate .c-u 1474 to 1659 186 to 1       186/186
(100 %)
0 diff
(100 %id)
AA292237 ovarian tumor, ovary .c-u 1479 to 1644 1 to 165       165/165
(100 %)
1 diff
(99.4 %id)
BE856019 Prostate .c-u 1481 to 1676 196 to 1       196/196
(100 %)
0 diff
(100 %id)
AA292685 ovarian tumor, ovary .c-u 1512 to 1660 149 to 1       149/149
(100 %)
0 diff
(100 %id)
BM126846 Islets of Langerhans, Pancreas .c-u 1512 to 1680 1 to 169       169/195
(86 %)
1 diff
(99.5 %id)
AI701604 Kidney .c-u 1513 to 1661 153 to 5       149/153
(97 %)
0 diff
(100 %id)
BM127481 Islets of Langerhans, Pancreas .c-u 1515 to 1680 1 to 166       166/192
(86 %)
2 diff
(99.0 %id)
EC520360 Prostate .c-u 1531 to 1628 1 to 98       98/98
(100 %)
0 diff
(100 %id)
N79056 lung Gene C11orf68, variant not shown         Suspected internal deletion, this clone was ignored    
W23998 lung Gene C11orf68, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI